
SAINT LOUIS, Mo. (May 26, 2026) — The U.S. Food and Drug Administration (FDA) has announced that Mogo Moringa LLC is voluntarily recalling select lots of its Mogo Moringa Oleifera Capsules due to a possible Salmonella contamination concern. According to the FDA, the recall applies only to two specific lots of the capsule product distributed through the company’s authorized online sales channels. Regulators said consumers who purchased the affected lots should stop using the product immediately.
Mogo recall: quick summary
According to the FDA, Mogo Moringa LLC voluntarily recalled select lots of its Moringa Oleifera Capsules after discussing potential Salmonella contamination concerns with federal regulators. The company said independent third-party laboratories tested retained samples from the affected lots and did not detect Salmonella, but Mogo chose to proceed with the recall as a precaution while the FDA continues its evaluation. Mogo packaged the affected products in white plastic bottles and sold them online through authorized channels only. The FDA has not received any reports of illnesses connected to the recall, and the company confirmed that no other Mogo products are affected.
Official recall details
✦
Recall issued date: May 25, 2026
✦
FDA publication date: May 26, 2026
✦
Announced by: U.S. Food and Drug Administration (FDA)
✦
Company: Mogo Moringa LLC
✦
Product name: Mogo Moringa Oleifera Capsules
✦
Issue involved: Possible Salmonella contamination
✦
Product packaging: White plastic bottle
✦
Affected lots:
Lot 00926AA – Exp. 01/2028 ||| Lot 15525AA – Exp. 06/2027
✦
Distribution: Sold online through authorized company channels
✦
Consumer guidance: Consumers are advised not to use products from the affected lots and should contact the company for additional support and recall instructions
✦
Want to know more about what happened? Keep reading.
What happened?
The FDA said Mogo Moringa LLC initiated the recall after discussing a possible Salmonella contamination concern with regulators involving specific lots of its Mogo Moringa Oleifera Capsules. The company announced the voluntary recall on May 25, 2026, in coordination with the FDA.
Mogo Moringa LLC, a Missouri-based supplement company, sells moringa-based wellness products online. The company said it sold the affected capsules in white plastic bottles through authorized online channels only and does not allow third-party sellers to distribute its products.
Mogo told regulators it identified the issue during discussions with the FDA. In its recall announcement, the company stated that “independent third-party laboratory testing tested retained samples from the affected lots and did not detect Salmonella.” However, Mogo said it chose to proceed with the recall “as a precaution and in coordination with the FDA while the agency continues its evaluation.”
The FDA warned consumers that Salmonella-contaminated products can pose serious health risks, especially for vulnerable populations. In its recall notice, the agency advised consumers with affected products not to use them.
Affected products
Brand | Product | Size | Best by date | Issue | Affected states or zones |
|---|---|---|---|---|---|
Mogo | Moringa Oleifera Capsules | White plastic bottle | 06/2027 | Possible Salmonella contamination | Online sales in the U.S. |
Mogo | Moringa Oleifera Capsules | White plastic bottle | 01/2028 | Possible Salmonella contamination | Online sales in the U.S. |
What caused the issue?
According to the FDA notice, Mogo Moringa LLC initiated the recall after identifying a potential Salmonella contamination concern involving two production lots of its Mogo Moringa Oleifera Capsules. The company said third-party laboratories tested retained samples from the affected lots and did not detect Salmonella, but company officials still chose to move forward with the recall as a precautionary measure.
Salmonella can cause serious and sometimes fatal infections, especially in young children, older adults, pregnant individuals, and people with weakened immune systems. Symptoms may include fever, diarrhea, nausea, vomiting, abdominal pain, and dehydration. In severe cases, the infection can spread to the bloodstream and cause more serious complications.
The agency confirmed that no illnesses related to the affected products have been reported so far. Company officials said they are continuing to cooperate closely with the FDA while strengthening internal testing and quality-control procedures.
Questions you might have
If you develop symptoms such as fever, diarrhea, nausea, or stomach cramps, contact a healthcare provider promptly.
Check the bottle label for Lot 15525AA or Lot 00926AA and the listed expiration dates.
Common symptoms include diarrhea, fever, vomiting, nausea, and abdominal cramps.
According to the FDA, no illnesses have been reported so far.
No. The recall only applies to two specific lots of Mogo Moringa Oleifera Capsules.
The capsules were sold online through authorized company sales channels.
Consumers are advised not to use the product and should follow the company’s recall guidance.
The company said it initiated the recall as a precaution while the FDA continues its evaluation.
Young children, older adults, pregnant individuals, and people with weakened immune systems face higher risks.
Consumers can reach Mogo Moringa LLC through the contact information provided on its official recall page.
Here’s what you should do
- Do not consume products from the affected lots
- Compare the lot number and expiration date on the bottle label with the recall notice
- Dispose of the product safely or contact the company regarding refund or replacement instructions
- Consumers can visit the company’s recall support page for assistance
Behind the brand
Mogo Moringa LLC operates as a Saint Louis-based wellness company that specializes in moringa supplements and plant-based health products. The company markets moringa as a nutrient-rich botanical that consumers commonly use in dietary supplements and wellness routines.
In its recall announcement, the company said it “remains committed to the quality, safety, and reliability of its products” and has “strengthened internal quality controls and testing procedures as part of its ongoing commitment to product excellence.”
Other relevant recalls
This latest supplement recall follows a broader pattern of contamination-related recalls affecting the wellness and dietary supplement industry in recent years. Similar contamination concerns have impacted a wide range of food and wellness products sold across the U.S. In recent months, companies including SKS Copack recalled various specialty beverages over possible Salmonella health risks, while Kroger issued a recall for Homestyle Cheese Garlic Croutons due to possible Salmonella contamination. Other recent recalls include Malazi Tahina products linked to Salmonella concerns and Blackstone Parmesan Ranch Seasoning recalled over a potential Salmonella health risk. Industry experts say these incidents demonstrate the continued importance of supplier verification, environmental monitoring, and rigorous testing throughout food and supplement supply chains.
Eran Mizrahi, CEO of Source86, said recalls like this one highlight the importance of traceability and supplier oversight throughout the supplement supply chain.
“Food safety isn’t just about compliance; it’s about trust. Every recall reminds us how vital it is to maintain transparency, rigorous checks, and supplier accountability,” Mizrahi said.
Broader pattern
This recall comes amid growing regulatory scrutiny surrounding dietary supplements and herbal wellness products sold online in the United States. Over the past several years, regulators have increased monitoring of contamination risks involving imported ingredients, botanical powders, and capsule-based supplements.
Industry experts say the rise in online supplement sales has made supply-chain transparency and quality assurance more important than ever, particularly for products marketed directly to consumers through e-commerce channels.
Ensuring safe eats
The Mogo recall underscores the importance of strong food and supplement safety systems across the wellness industry. Even precautionary recalls can significantly impact consumer trust and highlight the need for consistent testing, transparent sourcing, and rigorous quality assurance practices.
Consumers who purchased the affected lots should stop using the capsules immediately and follow the company’s recall instructions. This recall also reminds companies across the supplement industry to prioritize proactive contamination monitoring and maintain clear communication with regulators and customers.
At Source86, we help food and wellness brands strengthen ingredient sourcing, FSQA oversight, private label operations, and supply chain transparency so businesses can respond quickly and responsibly when recalls occur. Contact us.









